McIntosh I, Abbott M H, Francomano C A
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.
Hum Mutat. 1995;5(2):121-5. doi: 10.1002/humu.1380050204.
Schmid metaphyseal chondrodysplasia (SMCD) has previously been shown to be the result of mutations in the type X collagen gene, COL10A1. A further three mutations have been identified, including two nonsense mutations (Y268X, W651X) and a frameshift mutation (1856delCC). Each of the 10 SMCD mutations identified to date is within the C-terminal noncollagenous domain of type X collagen and three of five deletions initiated around the same nucleotide. This domain is believed to be involved in the initiation of collagen trimerization. The concentration of mutations within this domain is consistent with the hypothesis that the phenotype is the result of a reduction in the level of mature type X collagen due to the mutant polypeptide's inability to participate in trimer formation, although a dominant-negative mechanism cannot be discounted, on the basis of current evidence.
施密德干骺端软骨发育不良(SMCD)先前已被证明是X型胶原蛋白基因COL10A1发生突变的结果。又发现了另外三个突变,包括两个无义突变(Y268X、W651X)和一个移码突变(1856delCC)。迄今为止确定的10个SMCD突变均位于X型胶原蛋白的C端非胶原结构域内,且5个缺失中有3个在同一核苷酸附近起始。该结构域被认为参与胶原蛋白三聚体的起始。该结构域内突变的集中情况与以下假设一致,即该表型是由于突变多肽无法参与三聚体形成导致成熟X型胶原蛋白水平降低的结果,不过根据目前的证据,显性负性机制也不能排除。